| Identification | Back Directory | [Name]
L-Valine, glycyl-L-valyl-L-tyrosyl-L-α-aspartylglycyl-L-arginyl-L-α-glutamyl-L-histidyl-L-threonyl- | [CAS]
252875-61-9 | [Synonyms]
L-Valine, glycyl-L-valyl-L-tyrosyl-L-α-aspartylglycyl-L-arginyl-L-α-glutamyl-L-histidyl-L-threonyl- | [Molecular Formula]
C48H73N15O17 | [MOL File]
252875-61-9.mol | [Molecular Weight]
1132.18 |
| Hazard Information | Back Directory | [Uses]
MAGE A4 (230-239) is a peptide sequence derived from the MAGE-A4 protein. MAGE A4 (230-239) is an immunogenic epitope that can activate T cells and trigger the killing of tumor cells expressing MAGE-A4. MAGE A4 (230-239) is used in the development of next-generation T cell-based immunotherapies[1]. | [References]
[1] Davari K, et al. Development of a CD8 co-receptor independent T-cell receptor specific for tumor-associated antigen MAGE-A4 for next generation T-cell-based immunotherapy[J]. Journal for Immunotherapy of Cancer, 2021, 9(3). DOI:10.1136/jitc-2020-002035 |
|
|